S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   383.13 (-1.74%)
AAPL   161.84 (-1.17%)
MSFT   323.01 (-1.97%)
FB   306.84 (-1.14%)
GOOGL   2,840.03 (-0.67%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.46 (+1.78%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)

Agilent Technologies Stock Forecast, Price & News

$149.33
-1.66 (-1.10%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$147.72
$153.00
50-Day Range
$147.95
$166.38
52-Week Range
$112.47
$179.57
Volume
1.41 million shs
Average Volume
1.63 million shs
Market Capitalization
$45.21 billion
P/E Ratio
37.90
Dividend Yield
0.52%
Beta
0.98
30 days | 90 days | 365 days | Advanced Chart
Receive A News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.


Agilent Technologies logo

About Agilent Technologies

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Headlines

Agilent Technologies (NYSE:A) Issues Q1 2022 Earnings Guidance
November 29, 2021 |  americanbankingnews.com
Agilent Down 4% After Annual Revenue Guidance
November 23, 2021 |  marketwatch.com
Agilent Technologies (NYSE:A) Price Target Raised to $179.00
November 23, 2021 |  americanbankingnews.com
Agilent Technologies (NYSE:A) Price Target Raised to $187.00
November 23, 2021 |  americanbankingnews.com
Agilent Technologies (NYSE:A) PT Raised to $169.00 at Stifel Nicolaus
November 23, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
16,400
Year Founded
1999

Sales & Book Value

Annual Sales
$6.32 billion
Cash Flow
$5.36 per share
Book Value
$17.80 per share

Profitability

Net Income
$1.21 billion
Pretax Margin
21.52%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$45.21 billion
Optionable
Optionable

Company Calendar

Ex-Dividend
10/04/2021
Dividend Payable
10/27/2021
Last Earnings
11/22/2021
Today
12/03/2021
Next Earnings (Estimated)
2/15/2022
Fiscal Year End
10/31/2022

Social Links


MarketRank

Overall MarketRank

2.49 out of 5 stars

Computer And Technology Sector

172nd out of 890 stocks

Analytical Instruments Industry

3rd out of 33 stocks

Analyst Opinion: 1.5Community Rank: 4.9Dividend Strength: 3.3Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -












Agilent Technologies (NYSE:A) Frequently Asked Questions

Is Agilent Technologies a buy right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 hold rating and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Agilent Technologies stock.
View analyst ratings for Agilent Technologies
or view top-rated stocks.

How has Agilent Technologies' stock price been impacted by Coronavirus (COVID-19)?

Agilent Technologies' stock was trading at $68.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, A shares have increased by 116.9% and is now trading at $149.33.
View which stocks have been most impacted by COVID-19
.

When is Agilent Technologies' next earnings date?

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for Agilent Technologies
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) issued its quarterly earnings data on Monday, November, 22nd. The medical research company reported $1.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.17 by $0.04. The medical research company had revenue of $1.66 billion for the quarter, compared to analysts' expectations of $1.66 billion. Agilent Technologies had a trailing twelve-month return on equity of 26.71% and a net margin of 19.15%. The company's revenue was up 11.9% on a year-over-year basis. During the same period last year, the company earned $0.98 EPS.
View Agilent Technologies' earnings history
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies announced a quarterly dividend on Thursday, November 18th. Stockholders of record on Tuesday, January 4th will be given a dividend of $0.21 per share on Wednesday, January 26th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Monday, January 3rd. This is a positive change from Agilent Technologies's previous quarterly dividend of $0.19.
View Agilent Technologies' dividend history
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies pays an annual dividend of $0.78 per share and currently has a dividend yield of 0.52%. Agilent Technologies has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Agilent Technologies is 19.80%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 14.74% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.
View Agilent Technologies' dividend history.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies announced that its board has initiated a stock buyback plan on Tuesday, February 16th 2021, which authorizes the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 5% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its shares are undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its FY 2022 earnings guidance on Monday, November, 29th. The company provided earnings per share (EPS) guidance of $4.760-$4.860 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.240. The company issued revenue guidance of $6.65 billion-$6.73 billion, compared to the consensus revenue estimate of $6.01 billion.

What price target have analysts set for A?

15 brokers have issued twelve-month price targets for Agilent Technologies' stock. Their forecasts range from $51.00 to $195.00. On average, they anticipate Agilent Technologies' share price to reach $153.17 in the next twelve months. This suggests a possible upside of 2.6% from the stock's current price.
View analysts' price targets for Agilent Technologies
or view top-rated stocks among Wall Street analysts.

Who are Agilent Technologies' key executives?

Agilent Technologies' management team includes the following people:
  • Michael R. McMullen, President, Chief Executive Officer & Director
  • Robert W. McMahon, Chief Financial Officer & Senior Vice President
  • Darlene J. S. Solomon, Chief Technology Officer & Senior Vice President
  • Katharine Knobil, Chief Medical Officer
  • Michael Tang, Secretary, Senior Vice President & General Counsel (LinkedIn Profile)

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies CEO Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among Agilent Technologies' employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.08%), Wellington Management Group LLP (2.66%), Geode Capital Management LLC (1.90%), Invesco Ltd. (1.89%), Impax Asset Management Group plc (1.32%) and Arrowstreet Capital Limited Partnership (1.31%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends for Agilent Technologies
.

Which major investors are selling Agilent Technologies stock?

A stock was sold by a variety of institutional investors in the last quarter, including State Farm Mutual Automobile Insurance Co., Massachusetts Financial Services Co. MA, Artisan Partners Limited Partnership, Voya Investment Management LLC, Troy Asset Management Ltd, Bank of New York Mellon Corp, NFJ Investment Group LLC, and Invesco Ltd.. Company insiders that have sold Agilent Technologies company stock in the last year include Dominique Grau, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves, and Samraat S Raha.
View insider buying and selling activity for Agilent Technologies
or view top insider-selling stocks.

Which major investors are buying Agilent Technologies stock?

A stock was purchased by a variety of institutional investors in the last quarter, including Arrowstreet Capital Limited Partnership, Wellington Management Group LLP, BlackRock Inc., Two Sigma Advisers LP, American Century Companies Inc., Man Group plc, Goldman Sachs Group Inc., and Eagle Asset Management Inc..
View insider buying and selling activity for Agilent Technologies
or or view top insider-buying stocks.

How do I buy shares of Agilent Technologies?

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $149.33.

How much money does Agilent Technologies make?

Agilent Technologies has a market capitalization of $45.21 billion and generates $6.32 billion in revenue each year. The medical research company earns $1.21 billion in net income (profit) each year or $3.94 on an earnings per share basis.

How many employees does Agilent Technologies have?

Agilent Technologies employs 16,400 workers across the globe.

Does Agilent Technologies have any subsidiaries?

The following companies are subsidiares of Agilent Technologies: ACEA BIO, AT Singapore (Global) Pte Ltd., ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Rhone AG, Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako ApS, Dako Denmark, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.

When was Agilent Technologies founded?

Agilent Technologies was founded in 1999.

What is Agilent Technologies' official website?

The official website for Agilent Technologies is www.agilent.com.

Where are Agilent Technologies' headquarters?

Agilent Technologies is headquartered at 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051.

How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at (800) 227-9770, via email at [email protected], or via fax at 408-345-8474.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.